journal article·2022-04-01Open access

Predicting new potential antimalarial compounds by using Zagreb topological indices

Daniel Brito, Edgar Marquez, Felix Rosas, Ennis Rosas

AIP Advances· Volume 12· Issue 4

Abstract

Molecular topology allows describing molecular structures following a two-dimensional approach by taking into account how the atoms are arranged internally through a connection matrix between the atoms that are part of a structure. Various molecular indices (unique for each molecule) can be determined, such as Zagreb, Balaban, and topological indices. These indices have been correlated with physical chemistry properties such as molecular weight, boiling point, and electron density. Furthermore, their relationship with a specific biological activity has been found in other reports. Therefore, its knowledge and interpretation could be critical in the rational design of new compounds, saving time and money in their development process. In this research, the molecular graph of antimalarials already in the pharmaceutical market, such as chloroquine, primaquine, quinine, and artemisinin, was calculated and used to compute the Zagreb indices; a relationship between these indices and the antimalarial activities was found. According to the results reported in this work, the smaller the Zagreb indices, the higher the antimalarial activity. This relationship works very well for other compounds series. Therefore, it seems to be a fundamental structural requirement for this activity. Three triazole-modified structures are proposed as possible potential antimalarials based on this hypothesis. Finally, this work shows that the Zagreb indices could be a cornerstone in designing and synthesizing new antimalarial compounds, albeit they must be proved experimentally.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Computational Drug Discovery Methods · Synthesis and biological activity · Cholinesterase and Neurodegenerative Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Departamento de Matemáticas, Universidad de Oriente, Núcleo de Sucre 1 , Cumana, Venezuela

Grupo de Investigaciones en Química y Biología, Departamento de Química y Biología, Facultad de Ciencias Exactas, Universidad del Norte 2 , Carrera 51B, Km 5, vía Puerto Colombia, Barranquilla 081007, Colombia

Laboratorio de Fisicoquímica Orgánica, Instituto Venezolano de Investigaciones Científicas 3 , Caracas, Venezuela

Departamento de Ciencias Naturales y Exactas, Universidad de la Costa 4 , Barranquilla, Colombia

Funding

Universidad del Norte

References (59)

Show source-provided references
1. Malaria: The past and the present10.3390/microorganisms7060179 ↗
2. World Health Organization · 299
3. The global distribution of clinical episodes of Plasmodium falciparum malaria10.1038/nature03342 ↗
4. Global malaria mortality between 1980 and 2010: A systematic analysis10.1016/s0140-6736(12)60034-8 ↗
5. Malaria and COVID-19: Common and different findings10.3390/tropicalmed5030141 ↗
6. 2020
7. Socio-economic determinants of malaria in tribal dominated Mandla district enrolled in Malaria Elimination Demonstration Project in Madhya Pradesh10.1186/s12936-020-03540-x ↗
8. Poverty and malaria morbidity in the Jirapa district of Ghana: A count regression approach10.1080/23322039.2017.1293472 ↗
9. The impact of primary health care on malaria morbidity—Defining access by disease burden10.1111/j.1365-3156.2008.02194.x ↗
10. Environmental and sociodemographic factors associated with household malaria burden in the Congo10.1186/s12936-019-2679-0 ↗
11. The association between a conditional cash transfer programme and malaria incidence: A longitudinal ecological study in the Brazilian Amazon between 2004 and 201510.1186/s12889-021-11255-0 ↗
12. The global fight against malaria is at crossroads10.1016/s0140-6736(17)33080-5 ↗
13. Malaria: A problem to be solved and a time to be bold10.1038/s41591-021-01492-6 ↗
14. World Health Organization
15. Malaria infection and severe disease risks in Africa10.1126/science.abj0089 ↗
16. Declines in malaria burden and all-cause child mortality following increases in control interventions in Senegal, 2005–201010.4269/ajtmh.16-0953 ↗
17. Routine data for malaria morbidity estimation in Africa: Challenges and prospects10.1186/s12916-020-01593-y ↗
18. Malaria infection, disease and mortality among children and adults on the coast of Kenya10.1186/s12936-020-03286-6 ↗
19. Emergence and spread of kelch13 mutations associated with artemisinin resistance in Plasmodium falciparum parasites in 12 Thai provinces from 2007 to 201610.1128/AAC.02141-17 ↗
20. Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: An open-label, single-arm, multicentre, therapeutic efficacy study10.1016/s1473-3099(21)00142-0 ↗
21. Evidence of artemisinin-resistant malaria in Africa10.1056/NEJMoa2101746 ↗
22. Endoperoxide-based compounds: Cross-resistance with artemisinins and selection of a Plasmodium falciparum lineage with a K13 non-synonymous polymorphism10.1093/jac/dkx412 ↗
23. Cross-resistance of the chloroquine-derivative AQ-13 with amodiaquine in Cambodian Plasmodium falciparum isolates10.1093/jac/dkab219 ↗
24. Recent advances in quantitative structure–activity relationship models of antimalarial drugs10.1080/17460441.2021.1866535 ↗
25. Quantitative structure–activity relationship to predict the anti-malarial activity in a set of new imidazolopiperazines based on artificial neural networks10.1186/s12936-019-2941-5 ↗
26. Antimalarial alkoxylated and hydroxylated chalones: Structure–activity relationship analysis10.1021/jm0101747 ↗
27. A quantitative structure-activity relationship study on the antimalarial activities of 4-aminoquinoline, febrifugine and artemisinin compounds10.4018/ijqspr.2020010104 ↗
28. Synthesis, structure–activity relationship, and antimalarial efficacy of 6-chloro-2-arylvinylquinolines10.1021/acs.jmedchem.0c00858 ↗
29. Quantitative structure–activity relationships of natural-product-inspired, aminoalkyl-substituted 1-benzopyrans as novel antiplasmodial agents10.3390/molecules26175249 ↗
30. QSAR-based virtual screening of natural products database for identification of potent antimalarial hits10.3390/biom11030459 ↗
31. Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review10.1016/j.ejmech.2021.113705 ↗
32. Targeting and inhibiting Plasmodium falciparum using ultra-small gold nanoparticles10.1021/acsami.0c09075 ↗
33. Targeting the malaria parasite cGMP-dependent protein kinase to develop new drugs10.3389/fmicb.2020.602803 ↗
34. Targeting channels and transporters in protozoan parasite infections10.3389/fchem.2018.00088 ↗
35. Chemoproteomics for Plasmodium parasite drug target discovery10.1002/cbic.202100155 ↗
36. Repurposing drugs to target the malaria parasite unfolding protein response10.1038/s41598-018-28608-2 ↗
37. Molecular representations in AI-driven drug discovery: A review and practical guide10.1186/s13321-020-00460-5 ↗
38. The use of topological indices in QSAR and QSPR modeling
39. Masked graph modeling for molecule generation10.1038/s41467-021-23415-2 ↗
40. The first multiplication atom-bond connectivity index of molecular structures in drugs10.1016/j.jsps.2017.04.021 ↗
41. Topological properties of benzenoid, phenylenes and nanostar dendrimers10.1080/09720529.2019.1701267 ↗
42. Calculating degree based multiplicative topological indices of hyaluronic acid-paclitaxel conjugates’ molecular structure in cancer treatment10.1080/07391102.2020.1800512 ↗
43. Topological indices of some chemical structures applied for the treatment of COVID-19 patients10.1080/10406638.2020.1770306 ↗
44. Computational analysis of topological indices of two boron nanotubes10.1038/s41598-018-33081-y ↗
45. Study of biological networks using graph theory10.1016/j.sjbs.2017.11.022 ↗
46. Topological models for the prediction of anti-HIV activity of dihydro (alkylthio) (naphthylmethyl) oxopyrimidines10.1016/j.bmc.2004.12.014 ↗
47. PubChem, available at https://pubchem.ncbi.nlm.nih.gov/; accessed 30 September 2021.
48. In vitro antimalarial activity, β-haematin inhibition and structure–activity relationships in a series of quinoline triazoles10.1016/j.ejmech.2013.08.046 ↗
49. Synthesis of 2-amino-3-arylpropan-1-ols and 1-(2,3-diaminopropyl)-1,2,3-triazoles and evaluation of their antimalarial activity10.3762/bjoc.7.205 ↗
50. Plasmodium falciparum knockout for the GPCR-like PfSR25 receptor displays greater susceptibility to 1,2,3-triazole compounds that block malaria parasite development10.3390/biom10081197 ↗
51. Quinoline antimalarials: Mechanisms of action and resistance and prospects for new agents10.1016/s0163-7258(98)00012-6 ↗
52. A mechanism for primaquine mediated oxidation of NADPH in red blood cells10.1016/0006-2952(83)90305-2 ↗
53. High-throughput Plasmodium falciparum growth assay for malaria drug discovery10.1128/AAC.01144-06 ↗
54. 5-phenoxy primaquine analogs and the tetraoxane hybrid as antimalarial agents10.3390/molecules26133991 ↗
55. Artemisinin and its derivatives; ancient tradition inspiring the latest therapeutic approaches against malaria10.4155/fmc-2018-0337 ↗
56. Artemisinin and the antimalarial endoperoxides: From herbal remedy to targeted chemotherapy10.1128/mr.60.2.301-315.1996 ↗
57. Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu)10.1128/aac.37.5.1108 ↗
58. Exploration of artemisinin derivatives and synthetic peroxides in antimalarial drug discovery research10.1016/j.ejmech.2021.113193 ↗
59. Comparative whole genome transcriptome analysis of three Plasmodium falciparum strains10.1093/nar/gkj517 ↗